share_log

Short Interest in SQI Diagnostics Inc. (OTCMKTS:SQIDF) Increases By 18.7%

Short Interest in SQI Diagnostics Inc. (OTCMKTS:SQIDF) Increases By 18.7%

空頭股數在SQI診斷公司(場外市場代碼:SQIDF)的銷售額增長了18.7%
kopsource ·  2022/11/14 13:33

SQI Diagnostics Inc. (OTCMKTS:SQIDF – Get Rating) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 36,800 shares, an increase of 18.7% from the October 15th total of 31,000 shares. Based on an average daily volume of 159,500 shares, the days-to-cover ratio is presently 0.2 days.

SQI Diagnostics Inc.(場外交易市場代碼:SQIDF-GET Rating)是10月份空頭股數大幅增長的接受者。截至10月31日,空頭股數共有3.68萬股,比10月15日的3.1萬股增加了18.7%。以日均成交量159,500股計算,目前天數與回補比率為0.2天。

SQI Diagnostics Price Performance

SQI診斷性價比

Shares of SQIDF remained flat at $0.08 during mid-day trading on Friday. 66,700 shares of the stock traded hands, compared to its average volume of 55,483. The business has a 50 day simple moving average of $0.08 and a 200-day simple moving average of $0.11. SQI Diagnostics has a twelve month low of $0.06 and a twelve month high of $0.18.

在週五午盤交易中,SQIDF的股價持平於0.08美元。該股共有66,700股易手,而其平均成交量為55,483股。該業務的50日簡單移動均線切入位在0.08美元,200日簡單移動均線切入位在0.11美元。SQI診斷公司的12個月低點為0.06美元,12個月高位為0.18美元。

Get
到達
SQI Diagnostics
SQI診斷
alerts:
警報:

About SQI Diagnostics

關於SQI診斷公司

(Get Rating)

(獲取評級)

SQI Diagnostics Inc, a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test.
SQI診斷公司是一家精密醫療公司,為世界各地的醫療保健提供者、患者和消費者發現、開發和商業化快速診斷測試服務。它還提供TOR-DX肺部測試,使外科醫生能夠評估捐贈者的肺健康狀況;新冠肺炎在家抗體檢測試劑盒;RALI-Dx,新冠肺炎嚴重性分類實驗室測試;以及RALI-FAST,新冠肺炎嚴重性分類POC測試。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on SQI Diagnostics (SQIDF)
  • S&P 500 Component DexCom Set For Further Price, Earnings Growth
  • MarketBeat: Week in Review 11/7 – 11/11
  • Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
  • Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
  • Six Flags is a Ride You Don't Want to Get Stuck On
  • 免費獲取StockNews.com關於SQI診斷的研究報告(SQIDF)
  • 標準普爾500指數成分股DexCom將進一步上漲,收益增長
  • MarketBeat:回顧中的一週11/7-11/11
  • 油價是股市拋售尚未結束的一個令人信服的原因
  • 中盤Neurocrine生物科學是井噴後的第三季度報告嗎?
  • 六面旗幟是一種你不想被困住的旅程

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

接收SQI診斷日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對SQI診斷和相關公司的最新新聞和分析師評級的每日簡明摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論